Immunotherapy and Targeted Therapy for Cancer: A Patient Guide

Introduction

Hearing the word cancer can feel overwhelming. Then come the treatment names: chemotherapy, radiation, immunotherapy, targeted therapy. Many patients and families tell us the same thing. They want clear answers in simple language.

For many years, chemotherapy was the main drug treatment for cancer. It works by attacking fast-growing cells, which includes cancer cells but also healthy cells such as hair follicles and the lining of the gut. That is why chemotherapy often causes hair loss, nausea, and low blood counts.

Today, doctors have more precise options. Immunotherapy and targeted therapy are two of the most important advances in modern cancer care. They are built on a better understanding of how cancer grows and how it hides from the body’s defenses.

This guide explains both treatments in plain words. You will learn how they work, who may benefit, what side effects to expect, and what questions to ask your doctor. The information here follows guidance from trusted bodies such as the National Cancer Institute, ASCO Cancer.Net, the American Cancer Society, and the World Health Organization.

Cancer Treatment Beyond Chemotherapy: A Quick Overview

Cancer treatment usually falls into a few main groups.

• Surgery removes the tumor and, sometimes, nearby tissue.
• Radiation therapy uses high-energy beams to destroy cancer cells in a specific area.
• Chemotherapy uses drugs that travel through the blood to kill rapidly dividing cells.
• Hormone therapy blocks or lowers hormones that feed certain cancers, such as some breast and prostate cancers.
• Immunotherapy trains or boosts the immune system to fight cancer.
• Targeted therapy attacks specific features of cancer cells.

Immunotherapy, targeted therapy, and chemotherapy are all called systemic treatments, because they work throughout the body. Newer systemic options exist because scientists wanted treatments that are more precise. For the right patient, precision can mean better control of the disease and a different, sometimes more manageable, side effect profile.

What Is Immunotherapy?

How your immune system fights cancer

Your immune system is your body’s natural defense force. White blood cells, especially T cells, patrol your body looking for anything unusual, such as viruses, bacteria, and abnormal cells. When they spot a threat, they destroy it.

Cancer starts when normal cells change and grow out of control. Often, the immune system catches these cells early. But some cancer cells learn tricks to stay hidden. They may wear a kind of disguise or send signals that tell immune cells to stand down.

How immunotherapy works

Immunotherapy is a group of treatments that help the immune system do its job against cancer. Some remove the brakes that cancer has placed on immune cells. Others train immune cells to recognize cancer, or add extra immune proteins to strengthen the response.

Think of it this way. Chemotherapy attacks the cancer directly. Immunotherapy helps your body attack the cancer itself.

Main types of immunotherapy

1. Immune checkpoint inhibitors

Checkpoints are natural switches on immune cells that prevent them from attacking healthy tissue. Some cancers use these switches to avoid attack. Checkpoint inhibitors block these switches, which lets T cells recognize and fight the cancer. Common targets include PD-1, PD-L1, and CTLA-4. These are the most widely used form of immunotherapy today.

2. CAR T-cell therapy

In this treatment, a patient’s own T cells are collected from the blood and changed in a laboratory so they can recognize cancer cells. The cells are then returned to the body. CAR T-cell therapy is mainly used for certain blood cancers such as some leukemias and lymphomas. It is a specialized treatment given at advanced centers.

3. Monoclonal antibodies

These are lab-made proteins that attach to specific targets on cancer cells. Some mark the cancer cell so the immune system can find it. Some monoclonal antibodies act as targeted therapy and some as immunotherapy, depending on how they work.

4. Cancer vaccines

Treatment vaccines teach the immune system to recognize cancer-related proteins. This is different from preventive vaccines, such as the HPV vaccine or hepatitis B vaccine, which lower the risk of developing certain cancers.

5. Cytokines

Cytokines are natural immune messengers. Doctors can give lab-made versions, such as interleukins and interferons, to boost immune activity. They are used less often than checkpoint inhibitors today.

Cancers where immunotherapy is commonly used

Immunotherapy is approved for many cancer types. Examples include melanoma, lung cancer, kidney cancer, bladder cancer, head and neck cancer, some liver cancers, some colorectal cancers, and certain lymphomas. Approvals change over time as new research is published, so your oncologist can tell you what is currently available for your type and stage of cancer.

What Is Targeted Therapy?

How targeted therapy works

Every cell in your body is controlled by genes and proteins. In cancer cells, some of these genes are changed (mutated) or overactive. These changes act like a stuck accelerator pedal that keeps telling the cell to grow and divide.

Targeted therapy drugs are designed to find and block these specific changes. Because they focus on features that are common in cancer cells, they often cause less harm to normal cells than traditional chemotherapy. This does not mean they have no side effects, but the side effects are usually different.

Main types of targeted therapy

1. Small-molecule drugs

These are usually taken as tablets or capsules at home. They are small enough to enter cells and block the signals that drive growth. A well-known group is tyrosine kinase inhibitors, often called TKIs.

2. Monoclonal antibodies

Given by infusion, these antibodies attach to proteins on the surface of cancer cells. For example, some target HER2, a protein found in higher amounts in certain breast and stomach cancers.

3. Antibody-drug conjugates

These combine a targeted antibody with a chemotherapy drug. The antibody finds the cancer cell and delivers the drug directly to it, which can reduce harm to healthy tissue.

Common targets by cancer type

Here are some well-known examples, shown in general terms only. Your doctor will decide which drug, if any, fits your situation.

• EGFR and ALK changes: seen in some lung cancers.
• HER2: seen in some breast and stomach cancers.
• BRAF: seen in some melanomas and colorectal cancers.
• BRCA1 and BRCA2 (PARP inhibitors): seen in some breast, ovarian, prostate, and pancreatic cancers.
• BCR-ABL: seen in chronic myeloid leukemia.

Immunotherapy vs. Targeted Therapy: Key Differences at a Glance

The chart below gives a simple side-by-side view. Remember that individual experiences vary.

Factor	Immunotherapy	Targeted Therapy
Main idea	Boosts the immune system to fight cancer	Blocks specific molecules that help cancer grow
What decides eligibility	Immune markers such as PD-L1, MSI-H/dMMR, tumor mutational burden	Specific gene changes such as EGFR, ALK, HER2, BRAF
How it is given	Mostly IV infusion	Often tablets at home, some by IV
Speed of response	Can take weeks to months, but may last long	Often faster, but resistance may develop over time
Typical side effects	Immune-related inflammation, fatigue, rash, diarrhea	Skin changes, diarrhea, liver changes, blood pressure changes
Length of treatment	Fixed course or until it stops working	Often continued as long as it works
Works for everyone with that cancer?	No, depends on markers	No, only if the target is present

Who Is a Candidate? The Role of Biomarker Testing

This is one of the most important parts of modern cancer care. Before choosing immunotherapy or targeted therapy, doctors usually test the tumor to learn what is driving it.

What is biomarker testing?

A biomarker is a measurable sign found in your tumor, blood, or other tissue. Testing may be done on a biopsy sample or, in some cases, a blood test. Some tests look at one marker. Others, called comprehensive genomic profiling or next-generation sequencing, look at many genes at once.

Common biomarkers

Biomarker	What it tells your doctor	Treatment link
PD-L1	How much of a checkpoint protein the tumor shows	May help predict benefit from checkpoint inhibitors
MSI-H / dMMR	Whether the tumor has trouble repairing DNA errors	Often linked with good response to immunotherapy
Tumor mutational burden	How many mutations the tumor carries	May suggest immunotherapy could work
EGFR, ALK, ROS1	Gene changes in some lung cancers	Linked with targeted tablets
HER2	Protein level on cancer cells	Linked with HER2-targeted drugs
BRAF	Gene change in some cancers	Linked with BRAF-targeted drugs
BRCA1 / BRCA2	Inherited or acquired DNA repair gene changes	Linked with PARP inhibitors

Why testing should happen before treatment

Starting the wrong treatment can waste valuable time and may expose you to side effects without benefit. Testing helps match the drug to the tumor. It can also show which treatments are unlikely to work, which is equally useful.

What to Expect During Treatment

How treatment is given

Immunotherapy is usually given through a vein at a hospital or day-care infusion center. Each session may last from 30 minutes to a few hours. Sessions are often scheduled every two to six weeks, depending on the drug.

Many targeted therapies are tablets you take daily at home. This is convenient, but it needs discipline. Missing doses can reduce effectiveness, so use reminders and keep your pill schedule in a visible place.

Monitoring

Your care team will check how you are doing on a regular schedule. This may include:

• Blood tests to check liver, kidney, thyroid, and blood counts
• Imaging such as CT, MRI, or PET scans to see how the tumor is responding
• Regular visits to review symptoms and side effects

How long does treatment last?

There is no single answer. Some immunotherapy courses last up to about two years if the cancer responds well. Targeted therapy tablets are often continued for as long as they keep working and side effects are manageable. Your oncologist will review this with you at regular intervals.

Possible Side Effects and How They Are Managed

Both treatments can cause side effects. Knowing what to watch for helps you act early.

Immunotherapy side effects

Immunotherapy can sometimes cause the immune system to attack healthy organs. This is called an immune-related adverse event. It can occur at any time, even weeks or months after treatment starts.

Common effects include tiredness, skin rash or itching, diarrhea, cough, joint pain, and thyroid changes. Less common but serious effects can involve the lungs, liver, bowel, hormone glands, or nervous system.

Targeted therapy side effects

These depend on the drug. Common effects include skin rash or dry skin, diarrhea, mouth sores, tiredness, high blood pressure, liver enzyme changes, and swelling. Some drugs may affect the heart or eyes, so your doctor may arrange special checks.

Side effect comparison

Side effect	More common with immunotherapy	More common with targeted therapy
Fatigue	Yes	Yes
Skin rash or dryness	Yes	Yes, often more noticeable
Diarrhea	Yes, may signal bowel inflammation	Yes
Thyroid problems	Yes	Less common
High blood pressure	Less common	Yes, with some drugs
Liver changes	Yes	Yes
Hair loss	Uncommon	Uncommon, mild if present
Immune-related organ inflammation	Yes	No

Warning signs to report right away

Contact your oncology team immediately if you notice any of the following:

• Fever or chills
• Severe or persistent diarrhea, or blood in the stool
• Shortness of breath, new cough, or chest pain
• Yellowing of the skin or eyes
• Severe rash, blistering, or mouth ulcers
• Extreme tiredness, confusion, or severe headache
• Sudden weight change, or intense thirst and frequent urination

Early reporting matters a great deal. Most side effects are easier to control when caught early. Never stop treatment on your own, and do not wait for your next appointment if something feels wrong.

Combination Approaches

Doctors often combine treatments to improve results. Common combinations include:

• Immunotherapy with chemotherapy
• Immunotherapy with radiation therapy
• Two different immunotherapy drugs together
• Immunotherapy with a targeted drug
• Targeted therapy with hormone therapy or chemotherapy

The goal is to attack the cancer in more than one way. Combinations may improve response, but they can also increase side effects. Your oncologist will weigh the benefits and risks for your case.

Pros and Cons of Immunotherapy

Pros	Cons
Can produce long-lasting responses in some patients	Does not work for everyone
Works across many cancer types	Response may take weeks or months to show
Often has fewer chemotherapy-type side effects such as hair loss	Immune-related side effects can be serious and need quick attention
Immune memory may help protect against return of the cancer	Expensive, and may not be easily available everywhere
Can be combined with other treatments	Requires regular hospital visits for infusions

Pros and Cons of Targeted Therapy

Pros	Cons
Designed to hit specific cancer features	Works only if the target is present in your tumor
Many options are tablets taken at home	Cancer cells may become resistant over time
Often shows a quicker response	Needs daily discipline and regular monitoring
Usually spares more healthy cells than chemotherapy	Side effects such as rash, diarrhea, and liver changes can still occur
Can be effective even in advanced disease with the right target	Long-term use can be costly

Benefits, Limitations, and Realistic Expectations

Immunotherapy and targeted therapy have changed outcomes for many patients. Some people with advanced cancers have lived for years with good quality of life. Treatment is also becoming more personalized, which means fewer trial-and-error decisions.

Still, it is important to stay realistic.

• Not everyone responds. Even with the right marker, some tumors do not shrink.
• Resistance can develop. Cancer cells can change over time. When one drug stops working, your doctor may switch to another approach.
• These are not instant cures. They are powerful tools, used as part of a larger plan.
• Cost and access matter. In India, the price of some of these drugs can be high, and availability varies by city and hospital. Ask your care team about generic or biosimilar options, patient assistance programs, hospital support schemes, and insurance coverage before treatment begins. Planning the finances early can prevent interruptions in care.

Questions to Ask Your Oncologist

Going into an appointment prepared can make you feel more in control. Consider printing this checklist.

1. Is my type and stage of cancer suitable for immunotherapy or targeted therapy?
2. Which biomarker tests do I need, and when will I get the results?
3. What is the goal of this treatment: cure, control, or comfort?
4. What side effects should I watch for, and who do I call after hours?
5. How will we know if the treatment is working?
6. What happens if it stops working?
7. How much will the treatment cost, and are there support options?
8. Are there clinical trials that suit my situation?
9. Do my other medicines or health conditions affect this plan?
10. Should I get a second opinion?

Living Well During Treatment

Medical treatment is only one part of your care. Daily habits can help you feel stronger and more supported.

Nutrition. Eat small, balanced meals with enough protein. Drink plenty of fluids. If your appetite drops, ask your doctor about a dietitian. Always check with your care team before starting supplements or herbal products, because some can interfere with cancer drugs.

Rest and gentle movement. Fatigue is common. Short walks, light stretching, and good sleep habits often help. Listen to your body and rest when you need to.

Emotional support. Anxiety and low mood are normal during cancer care. Talk with family, friends, a counselor, or a support group. You do not need to carry this alone.

Involve your caregivers. Bring a family member to appointments. They can take notes, help with medicines, and notice changes you may miss.

Keep a symptom diary. Write down daily symptoms, medicines taken, and any questions. This gives your doctor accurate information and helps spot problems early.

Protect yourself from infections. Wash hands often, avoid sick contacts, and follow food safety rules, especially if your blood counts are low.

Frequently Asked Questions

Is immunotherapy better than chemotherapy?

Not always. It depends on the cancer type, stage, and biomarkers. For some cancers, immunotherapy has improved survival compared with chemotherapy. For others, chemotherapy remains the standard, or the two are used together. Your oncologist will choose based on evidence for your specific situation.

Can immunotherapy and targeted therapy be used together?

In some cases, yes. Certain combinations are approved or being studied in clinical trials. Whether it is safe and useful depends on the cancer type and your overall health.

How long does it take for immunotherapy to work?

Some patients see a response within a few weeks. For others, it takes a few months. Occasionally, scans may look worse before they improve because immune cells gather around the tumor. Your doctor will interpret scan results with this in mind.

Are targeted therapy drugs taken at home?

Many are. Tablets and capsules are common. Others, such as monoclonal antibodies and antibody-drug conjugates, are given by infusion at a hospital or day-care center.

Does immunotherapy cause hair loss?

Hair loss is uncommon with immunotherapy compared with chemotherapy. Some patients may notice mild thinning, but significant hair loss is not typical.

Is immunotherapy available for all types of cancer?

No. It is approved for many cancers, but not all. Benefit also depends on the tumor’s biology. Ask your oncologist whether your cancer type has an approved option or an open clinical trial.

Can I stop treatment if I feel better?

No. Feeling better does not always mean the cancer is gone. Stop or change treatment only when your oncologist advises it.

Final Thoughts

Immunotherapy and targeted therapy are two of the biggest advances in cancer care. Immunotherapy helps your immune system find and fight cancer. Targeted therapy blocks the exact signals that cancer cells use to grow. Both depend on careful testing, close monitoring, and a treatment plan built around you.

The key points to remember are simple. Ask for biomarker testing early. Report side effects quickly. Keep realistic expectations, and do not hesitate to ask questions or seek a second opinion. Having clear information can reduce fear and help you make confident decisions with your family and doctors.

If you or a loved one needs expert guidance on cancer treatment options, you can reach the specialist team at Subha Cancer Care to discuss a personalized plan.